NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.

NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome. Clin Cancer Res. 2018 03 01; 24(5):1019-1029.

View in: PubMed

subject areas

Aged
Antigens, Neoplasm
Antimetabolites, Antineoplastic
Cancer Vaccines
Carboxymethylcellulose Sodium
Combined Modality Therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Feasibility Studies
Humans
Immunotherapy
Interferon Inducers
Leukemia, Myeloid, Acute
Membrane Proteins
Middle Aged
Myelodysplastic Syndromes
Myeloid Cells
Poly I-C
Polylysine
T-Lymphocytes, Cytotoxic
Treatment Outcome

authors with profiles

Junko Matsuzaki
Gregory Roloff